| 國立臺灣大學 |
1986 |
Glaucomatomatocyclitic Crisis and Primary Open-Angle Glaucoma
|
洪伯廷; Shih, Y. F.; Hung, Por-Tying; Shih, Y. F. |
| 中國醫藥大學 |
2015-11 |
Glaucumolides A and B, Biscembranoids with New Structural Type from a Cultured Soft Coral Sarcophyton glaucum
|
(Huang, Chiung-Yao);(Sung, Ping-Jyun);(Uvarani, Chokkalingam);(Su, Jui-Hsin);(Lu, Mei-Chin);(Hwang, Tsong-Long);(Dai, Chang-Feng);(Wu, Shwu-Li);許志宏(Jyh-Horng Sheu)* |
| 國立高雄應用科技大學 |
2005-02 |
Glazed Tiles Manufactured from Incinerated Sewage Sludge Ash and Clay
|
Lin, Deng-Fong; Luo, Huan-Lin; Sheen, Yeong-Nain |
| 義守大學 |
2005-02 |
Glazed tiles manufactured from incinerated sewage sludge ash and clay
|
Deng-Fong Lin;Huan-Lin Luo;Yeong-Nain Sheen |
| 國立高雄大學 |
2005 |
Glazed Tiles Manufactured from Incinerated Sewage Sludge Ash by Using Different Colorants
|
Lin, D.F.; Chang, W.C.; Yuan, C.; Luo, H.L. |
| 義守大學 |
2005-08 |
Glazed Tiles Manufactured from Incinerated Sewage Sludge Ash by Using Different Colorants
|
Lin, Deng-Fong; Luo, Huan-Lin; Sheen, Yeong-Nain |
| 臺大學術典藏 |
2018-09-10T04:30:53Z |
GLC project: Linear collider for TeV physics
|
Abe, Koya; Abe, Koya; MIN-ZU WANG |
| 臺大學術典藏 |
2018-09-10T05:55:15Z |
GLD Detector Outline Document: Version 1.2
|
Abe, Koh; Abe, Koh; MIN-ZU WANG |
| 中山醫學大學 |
2020 |
Glecaprevir-pibrentasvir for chronic hepatitis C: Comparing treatment effect in patients with and without end-stage renal disease in a real-world setting
|
Yen, HH; Su, PY; Zeng, YH; Liu, IL; Huang, SP; Hsu, YC; Chen, YY; Yang, CW; Wu, SS; Chou, KC |
| 臺大學術典藏 |
2021-07-03T03:33:26Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu C.-H.; Yang S.-S.; Peng C.-Y.; Lin W.-T.; Liu C.-J.; Su T.-H.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2020-11-03T08:19:41Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment
|
Kao J.-H.; Chen D.-S.; Chen P.-J.; Tseng T.-C.; Su T.-H.; Liu C.-J.; CHEN-HUA LIU; Yang S.-S.; Peng C.-Y.; Lin W.-T. |
| 臺大學術典藏 |
2021-05-24T07:20:18Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment
|
CHEN-HUA LIU; Yang S.-S.; Peng C.-Y.; Lin W.-T.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T05:16:37Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu C.-H.; Yang S.-S.; Peng C.-Y.; Lin W.-T.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-01-24T09:31:09Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu C.-H.; Yang S.-S.; Peng C.-Y.; Lin W.-T.; CHUN-JEN LIU; Su T.-H.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:43:12Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu C.-H.; Yang S.-S.; Peng C.-Y.; Lin W.-T.; Liu C.-J.; TUNG-HUNG SU; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 中山醫學大學 |
2020 |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu, CH; Yang, SS; Peng, CY; Lin, WT; Liu, CJ; Su, TH; Tseng, TC; Chen, PJ; Chen, DS; Kao, JH |
| 臺大學術典藏 |
2020-09-30T03:22:14Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan
|
Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.; Liu C.-H.;Liu C.-J.;Chien-Ching Hung;Hsieh S.-M.;Su T.-H.;Sun H.-Y.;Tseng T.-C.;Chen P.-J.;Chen D.-S.;Kao J.-H.; Liu C.-H.; Liu C.-J.; CHIEN-CHING HUNG; Hsieh S.-M.; Su T.-H.; Sun H.-Y. |
| 臺大學術典藏 |
2020-11-03T08:19:42Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan
|
CHEN-HUA LIU; Liu C.-J.; Hung C.-C.; Hsieh S.-M.; Su T.-H.; Sun H.-Y.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2020-12-29T05:33:43Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan
|
Chen D.-S.; Tseng T.-C.; Chen P.-J.; HSIN-YUN SUN; Su T.-H.; Hsieh S.-M.; Hung C.-C.; Liu C.-J.; Liu C.-H.; Kao J.-H. |
| 臺大學術典藏 |
2020-12-29T06:37:44Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan
|
Hung C.-C.; SZU-MIN HSIEH; Liu C.-J.; Liu C.-H.; Su T.-H.; Sun H.-Y.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:43:13Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan
|
Liu C.-H.; Liu C.-J.; Hung C.-C.; Hsieh S.-M.; TUNG-HUNG SU; Sun H.-Y.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:19Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan
|
CHEN-HUA LIU; Liu C.-J.; Hung C.-C.; Hsieh S.-M.; Su T.-H.; Sun H.-Y.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T05:16:40Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan
|
Liu C.-H.; Liu C.-J.; Hung C.-C.; Hsieh S.-M.; Su T.-H.; Sun H.-Y.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-12-01T02:29:06Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan
|
Liu C.-H.; Liu C.-J.; CHIEN-CHING HUNG; Hsieh S.-M.; Su T.-H.; Sun H.-Y.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:10Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan
|
Liu C.-H.; CHUN-JEN LIU; Hung C.-C.; Hsieh S.-M.; Su T.-H.; Sun H.-Y.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
